“Fine Foods & Pharmaceuticals NTM closes 2019 with a 15% growth in revenues of 160 million and a confirmation of the adjusted margins, while the punctual ones slow down due to the costs related to the expansion of Zingonia (Food) and Brembate (Pharma), where the activities of the Nembro plant have been transferred.

Also in this 2020 characterized by the Covid-19 pandemic, the company has never stopped the production and the development of drugs and food supplements, also confirming the desire to switch to MTA after the emergency has been overcome.”

Read the full article (italian only)

Link to the article on Market Insight website (italian only)